Company intelligence / Profile preview

RightBio Metrics

Scottsdale, Arizona, United Statesrightbiometrics.com ↗

Ownership: Private
Employees: ~100
Development stage: Other

Overview

RightBio Metrics has developed and commercialized the RightSpotpH Indicator, a diagnostic device that provides rapid, accurate confirmation of NG/OG tube placement using pH measurement. The technology is FDA-cleared, widely adopted in clinical settings including NICU, ICU/PICU, emergency departments, and point-of-care testing environments. Clinical studies support its effectiveness in reducing harm from misplaced tubes[1][2][5].

Therapeutic areas: Gastroenterology
Modalities: DeviceDiagnostic device (pH indicator for tube placement)
Industry: Metabolite Diagnostics

Partnerships

Collaborations with leading medical institutions and researchers for clinical research and education[1]

Beyond the preview

Go deeper on RightBio Metrics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RightBio Metrics.

Explore the full profile